Acer Therapeutics Inc buy krebskrebs
Start price
01.11.21
/
50%
€2.04
Target price
01.11.22
€2.50
Performance (%)
-37.38%
End price
02.11.22
€1.28
Summary
This prediction ended on 02.11.22 with a price of €1.28. The BUY prediction by krebskrebs for Acer Therapeutics Inc performed very badly with a performance of -37.38%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Acer Therapeutics Inc | - | - | - |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
Comments by krebskrebs for this prediction
In the thread Acer Therapeutics Inc diskutieren
Buy mit Kursziel 2,5
In the thread Trading Acer Therapeutics Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten